Table 3a. The results of the univariate analysis for survival.
| Variable | Category | Patient number | Overall 2-year survival (%) | P-value |
|---|---|---|---|---|
| Age | ⩽65 | 34 | 66.0 | 0.5670 |
| |
⩾66 |
67 |
60.7 |
|
| Sex | Male | 89 | 62.9 | 0.2495 |
| |
Female |
12 |
66.7 |
|
| Tumour depth | T1–2 | 48 | 96.4 | <0.0001 |
| |
T3–4 |
53 |
31.9 |
|
| Lymph node metastasis | Negative | 46 | 94.7 | <0.0001 |
| |
Positive |
55 |
34.1 |
|
| Distant metastasis | Negative | 85 | 66.9 | 0.0005 |
| |
Positive |
16 |
38.1 |
|
| CEA | ⩽5.2 | 86 | 63.3 | 0.7978 |
| |
>5.2 |
15 |
63.5 |
|
| SCC | ⩽1.5 | 62 | 69.3 | 0.0595 |
| |
>1.5 |
39 |
48.3 |
|
| miR-1246 | ⩽Mean | 73 | 77.3 | <0.0001 |
| >Mean | 28 | 21.7 |
Abbreviations: CEA=carcinoembryonic antigen; SCC=squamous cell carcinoma. Bold numbers indicate the significance level was set at P<0.05.